Fiscal year 2019 was a strong year for National Jewish Health with ongoing financial success. Net patient service revenue grew 5 percent to $148 million. Demand for our unique, patient-centered approach continues to exceed our capacity.

Accordingly, a significant focus during the year was on expanding availability for patients with the recruitment of new providers in cardiology, pulmonology, gastroenterology, infectious disease and pediatrics. Though we practice at over 25 locations in Colorado, expansion is only possible on our main campus with the addition of clinic space. During the year, we worked with our partners at SCL Health to finance the new Center for Outpatient Health, which will significantly increase our clinical footprint providing more exam rooms, a state-of-the-art infusion center and allowing for the expansion of our diagnostic services. The Board of Directors from both National Jewish Health and SCL Health approved a financing mechanism, allowing National Jewish Health to access the bond markets with a guarantee from SCL Health. This financing augments the generous gifts given to our Comprehensive Campaign and enables us to build this much needed facility earlier than would otherwise be possible. We closed on this financing in October 2019.

Download Documents

Financial Charts

IRS Form 990 (PDF)
"Return of Organization Exempt From Income Tax" for your records

2019 Community Health Needs Assessment and Implementation Strategy

2019 Annual Report (PDF)

2019 Statement of Activities (PDF)

Audited Financial Statement (PDF)

A primary focus of our strategic plan has been the development of new programs and revenue sources. One of these new revenue streams is the expansion of pharmacy access for our patients around the country, including specialty pharmacies. This revenue stream provided $23.6 million in gross revenues in 2019.

Our Respiratory Institutes® around the country continue to exceed expectations with a new site and additional programs. Revenues from joint ventures decreased from 2018, as a result of the strong performance of the National Jewish Health stand-alone clinical programs.

National Jewish Health continues to expand and diversify our research portfolio. Grant revenue increased over 10 percent. With the help of our dedicated donors, development raised $24 million. This represents a decline of $9.5 million over 2018, which was the highest ever due to one very generous gift. The investment markets were tumultuous during the year but, due to the National Jewish Health diversified portfolio, investment revenues ended the year only $1.9 million lower than in 2018. Overall, total revenues were more than $16 million higher than in the prior year.

Revenue for 2019